Funding agencies: Supported in part by the National Institutes of Health (RO1NS077851, RO1MH094741 to J.D.), the National Cancer Institute (RO1CA089054 to J.D.), Fondo de Investigaciones Sanitarias (FIS) (11/01780 to J.D.), and Fundació la Marató de TV3 (to J.D.).
Anti–N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness
Article first published online: 29 MAY 2013
Copyright © 2013 Movement Disorder Society
Volume 28, Issue 6, pages 820–822, June 2013
How to Cite
Labate, A., Quattrone, A., Dalmau, J. and Gambardella, A. (2013), Anti–N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness. Mov. Disord., 28: 820–822. doi: 10.1002/mds.25510
Relevant conflicts of interest/financial disclosures: J.D. has a research grant from Euroimmun, and receives royalties from patents for the use of Ma2 and NMDAR as autoantibody tests.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 25 JUN 2013
- Article first published online: 29 MAY 2013
- Manuscript Revised: 9 APR 2013
- Manuscript Accepted: 9 APR 2013
- Manuscript Received: 30 AUG 2012
This article has been cited by:
- 2Reversible symmetrical external capsule hyperintensity as an early finding of autoimmune encephalitis, Neurological Sciences, 2014, 35, 7, 1147, , , , ,
- 3Sudden and isolated Broca's aphasia: A new clinical phenotype of anti NMDA receptor antibodies encephalitis in children, European Journal of Paediatric Neurology, 2014, 18, 6, 790, , , , , , ,
- 4Three Phenotypes of Anti–N-Methyl-d-Aspartate Receptor Antibody Encephalitis in Children: Prevalence of Symptoms and Prognosis, Pediatric Neurology, 2014, 51, 4, 542, , ,